US Stock MarketDetailed Quotes

KURA Kura Oncology

Watchlist

10.060
-5.850-36.77%

Close Nov 21 16:00 ET

782.30MMarket Cap-4280P/E (TTM)

Kura Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-49.65%-43.44M

-66.02%-42.53M

-36.16%-48.84M

-13.41%-124.82M

-29.32%-34.31M

-38.16%-29.03M

15.57%-25.62M

-11.47%-35.87M

-5.27%-110.06M

-13.54%-26.53M

Net income from continuing operations

-40.94%-54.4M

-36.75%-50.84M

-45.37%-49.53M

-12.36%-152.63M

-29.21%-42.79M

-8.73%-38.6M

-6.92%-37.17M

-4.98%-34.07M

-4.12%-135.84M

-1.13%-33.11M

Depreciation and amortization

-3.70%208K

-5.16%202K

13.59%234K

11.86%849K

3.88%214K

11.92%216K

16.39%213K

16.38%206K

36.02%759K

24.10%206K

Other non cash items

9.84%134K

4.96%127K

6.09%122K

553.42%477K

--119K

--122K

--121K

--115K

-81.70%73K

----

Change In working capital

13.86%5.74M

-51.20%3.1M

32.41%-4.92M

362.21%7.82M

2,309.74%3.71M

-33.51%5.04M

307.59%6.35M

4.96%-7.28M

7.51%-2.98M

-90.36%154K

-Change in prepaid assets

-55.38%357K

30.86%2.46M

-3.79%-2.19M

33.22%-1.96M

-287.43%-2.53M

-12.28%800K

173.30%1.88M

19.81%-2.11M

-722.13%-2.94M

19.54%1.35M

-Change in payables and accrued expense

44.35%5.68M

-101.22%-50K

41.69%-3.13M

1,387.66%10.33M

590.13%7.65M

-38.08%3.93M

1,306.16%4.11M

-2.15%-5.36M

68.15%-802K

-5,132.26%-1.56M

-Change in other current assets

-284.06%-508K

70.03%539K

24.86%231K

-219.96%-685K

-524.06%-1.46M

19.48%276K

388.18%317K

76.19%185K

273.56%571K

-17.27%345K

-Change in other current liabilities

624.14%210K

336.36%144K

1,200.00%169K

-25.54%137K

264.71%62K

-65.06%29K

189.19%33K

-89.26%13K

1,020.00%184K

-10.53%17K

Cash from discontinued investing activities

Operating cash flow

-49.65%-43.44M

-66.02%-42.53M

-36.16%-48.84M

-13.41%-124.82M

-29.32%-34.31M

-38.16%-29.03M

15.57%-25.62M

-11.47%-35.87M

-5.27%-110.06M

-13.54%-26.53M

Investing cash flow

Cash flow from continuing investing activities

432.01%45.54M

193.18%43.17M

-956.65%-95.34M

-52.32%15.56M

189.17%42.2M

-88.08%8.56M

-239.97%-46.33M

144.58%11.13M

125.72%32.63M

-163.89%-47.32M

Net PPE purchase and sale

--0

83.33%-16K

-133.33%-84K

73.16%-168K

-33.33%-16K

94.75%-20K

47.83%-96K

26.53%-36K

45.42%-626K

88.24%-12K

Net investment purchase and sale

430.77%45.54M

193.41%43.18M

-953.14%-95.25M

-52.71%15.73M

189.23%42.21M

-88.12%8.58M

-238.91%-46.23M

144.82%11.17M

126.46%33.25M

-163.79%-47.31M

Cash from discontinued investing activities

Investing cash flow

432.01%45.54M

193.18%43.17M

-956.65%-95.34M

-52.32%15.56M

189.17%42.2M

-88.08%8.56M

-239.97%-46.33M

144.58%11.13M

125.72%32.63M

-163.89%-47.32M

Financing cash flow

Cash flow from continuing financing activities

2,521.43%2.2M

-96.77%3.04M

148.37M

145.77%94.78M

-98.01%691K

-90.45%84K

3,422.22%94.01M

1,222.71%38.57M

4,271.91%34.71M

Net issuance payments of debt

----

--0

----

237.93%10M

----

Net common stock issuance

--0

--145.81M

278.53%93.58M

--0

--93.58M

--0

--24.72M

Proceeds from stock option exercised by employees

2,521.43%2.2M

605.34%3.04M

--2.56M

-72.71%1.21M

21.87%691K

-90.45%84K

-83.85%431K

--0

-0.16%4.42M

-28.59%567K

Net other financing activities

----

5.89%-575K

----

Cash from discontinued financing activities

Financing cash flow

2,521.43%2.2M

-96.77%3.04M

--148.37M

145.77%94.78M

-98.01%691K

-90.45%84K

3,422.22%94.01M

--0

1,222.71%38.57M

4,271.91%34.71M

Net cash flow

Beginning cash position

-8.02%45.18M

53.39%41.51M

-27.96%37.32M

-42.87%51.8M

-68.40%28.74M

24.47%49.12M

-20.51%27.06M

-43.00%51.8M

-72.16%90.67M

130.85%90.94M

Current changes in cash

121.08%4.3M

-83.34%3.68M

116.93%4.19M

62.74%-14.48M

121.92%8.58M

-139.44%-20.38M

306.73%22.07M

56.47%-24.74M

83.45%-38.87M

-176.01%-39.14M

End cash Position

72.16%49.48M

-8.02%45.18M

53.39%41.51M

-27.96%37.32M

-68.40%28.74M

24.47%49.12M

-20.51%27.06M

-43.00%51.8M

Free cash flow

-49.55%-43.44M

-65.46%-42.55M

-36.26%-48.93M

-12.92%-124.99M

-29.32%-34.32M

-35.79%-29.05M

15.76%-25.71M

-11.41%-35.91M

-4.72%-110.69M

-13.10%-26.54M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-49.65%-43.44M	-66.02%-42.53M	-36.16%-48.84M	-13.41%-124.82M	-29.32%-34.31M	-38.16%-29.03M	15.57%-25.62M	-11.47%-35.87M	-5.27%-110.06M	-13.54%-26.53M
Net income from continuing operations	-40.94%-54.4M	-36.75%-50.84M	-45.37%-49.53M	-12.36%-152.63M	-29.21%-42.79M	-8.73%-38.6M	-6.92%-37.17M	-4.98%-34.07M	-4.12%-135.84M	-1.13%-33.11M
Depreciation and amortization	-3.70%208K	-5.16%202K	13.59%234K	11.86%849K	3.88%214K	11.92%216K	16.39%213K	16.38%206K	36.02%759K	24.10%206K
Other non cash items	9.84%134K	4.96%127K	6.09%122K	553.42%477K	--119K	--122K	--121K	--115K	-81.70%73K	----
Change In working capital	13.86%5.74M	-51.20%3.1M	32.41%-4.92M	362.21%7.82M	2,309.74%3.71M	-33.51%5.04M	307.59%6.35M	4.96%-7.28M	7.51%-2.98M	-90.36%154K
-Change in prepaid assets	-55.38%357K	30.86%2.46M	-3.79%-2.19M	33.22%-1.96M	-287.43%-2.53M	-12.28%800K	173.30%1.88M	19.81%-2.11M	-722.13%-2.94M	19.54%1.35M
-Change in payables and accrued expense	44.35%5.68M	-101.22%-50K	41.69%-3.13M	1,387.66%10.33M	590.13%7.65M	-38.08%3.93M	1,306.16%4.11M	-2.15%-5.36M	68.15%-802K	-5,132.26%-1.56M
-Change in other current assets	-284.06%-508K	70.03%539K	24.86%231K	-219.96%-685K	-524.06%-1.46M	19.48%276K	388.18%317K	76.19%185K	273.56%571K	-17.27%345K
-Change in other current liabilities	624.14%210K	336.36%144K	1,200.00%169K	-25.54%137K	264.71%62K	-65.06%29K	189.19%33K	-89.26%13K	1,020.00%184K	-10.53%17K
Cash from discontinued investing activities
Operating cash flow	-49.65%-43.44M	-66.02%-42.53M	-36.16%-48.84M	-13.41%-124.82M	-29.32%-34.31M	-38.16%-29.03M	15.57%-25.62M	-11.47%-35.87M	-5.27%-110.06M	-13.54%-26.53M
Investing cash flow
Cash flow from continuing investing activities	432.01%45.54M	193.18%43.17M	-956.65%-95.34M	-52.32%15.56M	189.17%42.2M	-88.08%8.56M	-239.97%-46.33M	144.58%11.13M	125.72%32.63M	-163.89%-47.32M
Net PPE purchase and sale	--0	83.33%-16K	-133.33%-84K	73.16%-168K	-33.33%-16K	94.75%-20K	47.83%-96K	26.53%-36K	45.42%-626K	88.24%-12K
Net investment purchase and sale	430.77%45.54M	193.41%43.18M	-953.14%-95.25M	-52.71%15.73M	189.23%42.21M	-88.12%8.58M	-238.91%-46.23M	144.82%11.17M	126.46%33.25M	-163.79%-47.31M
Cash from discontinued investing activities
Investing cash flow	432.01%45.54M	193.18%43.17M	-956.65%-95.34M	-52.32%15.56M	189.17%42.2M	-88.08%8.56M	-239.97%-46.33M	144.58%11.13M	125.72%32.63M	-163.89%-47.32M
Financing cash flow
Cash flow from continuing financing activities	2,521.43%2.2M	-96.77%3.04M	148.37M	145.77%94.78M	-98.01%691K	-90.45%84K	3,422.22%94.01M	0	1,222.71%38.57M	4,271.91%34.71M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	237.93%10M	----
Net common stock issuance	--0	--0	--145.81M	278.53%93.58M	--0	--0	--93.58M	--0	--24.72M	--24.72M
Proceeds from stock option exercised by employees	2,521.43%2.2M	605.34%3.04M	--2.56M	-72.71%1.21M	21.87%691K	-90.45%84K	-83.85%431K	--0	-0.16%4.42M	-28.59%567K
Net other financing activities	----	----	----	----	----	----	----	----	5.89%-575K	----
Cash from discontinued financing activities
Financing cash flow	2,521.43%2.2M	-96.77%3.04M	--148.37M	145.77%94.78M	-98.01%691K	-90.45%84K	3,422.22%94.01M	--0	1,222.71%38.57M	4,271.91%34.71M
Net cash flow
Beginning cash position	-8.02%45.18M	53.39%41.51M	-27.96%37.32M	-42.87%51.8M	-68.40%28.74M	24.47%49.12M	-20.51%27.06M	-43.00%51.8M	-72.16%90.67M	130.85%90.94M
Current changes in cash	121.08%4.3M	-83.34%3.68M	116.93%4.19M	62.74%-14.48M	121.92%8.58M	-139.44%-20.38M	306.73%22.07M	56.47%-24.74M	83.45%-38.87M	-176.01%-39.14M
End cash Position	72.16%49.48M	-8.02%45.18M	53.39%41.51M	-27.96%37.32M	-27.96%37.32M	-68.40%28.74M	24.47%49.12M	-20.51%27.06M	-43.00%51.8M	-43.00%51.8M
Free cash flow	-49.55%-43.44M	-65.46%-42.55M	-36.26%-48.93M	-12.92%-124.99M	-29.32%-34.32M	-35.79%-29.05M	15.76%-25.71M	-11.41%-35.91M	-4.72%-110.69M	-13.10%-26.54M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data